Search

Your search keyword '"INSERM CIC 0802 (INSERM - CHU de Poitiers)"' showing total 47 results

Search Constraints

Start Over You searched for: Author "INSERM CIC 0802 (INSERM - CHU de Poitiers)" Remove constraint Author: "INSERM CIC 0802 (INSERM - CHU de Poitiers)"
47 results on '"INSERM CIC 0802 (INSERM - CHU de Poitiers)"'

Search Results

1. Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

2. Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system

3. T-piece versus pressure-support ventilation for spontaneous breathing trials before extubation in patients at high risk of reintubation: protocol for a multicentre, randomised controlled trial (TIP-EX)

4. Supplementary material: Plasma Trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes

5. Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies

6. Impact of operation conditions, foulant adsorption, and chemical cleaning on the nanomechanical properties of ultrafiltration hollow fiber membranes

7. Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cells

8. Study of a novel agent for TCA precipitated proteins washing - comprehensive insights into the role of ethanol/HCl on molten globule state by multi-spectroscopic analyses

9. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid

10. Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer

11. A dendritic β-galactosidase-responsive folate–monomethylauristatin E conjugate

12. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis

13. The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia

14. Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study

15. Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population

16. A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells

17. Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

18. Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

19. Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

20. Association of postpartum depressive symptoms and urinary incontinence. A cohort study

21. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy

22. Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate

23. The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia

24. The individual determinants of care-seeking among middle-aged women reporting urinary incontinence: Analysis of a 2273-woman cohort.: The determinants of care-seeking among women reporting urinary incontinence

25. Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib

26. beta-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update

27. Neurocognitive Outcome of Children Exposed to Perinatal Mother-to-Child Chikungunya Virus Infection: The CHIMERE Cohort Study on Reunion Island

28. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

29. The individual determinants of care-seeking among middle-aged women reporting urinary incontinence: Analysis of a 2273-woman cohort.: The determinants of care-seeking among women reporting urinary incontinence

30. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection

31. An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process

32. Urinary incontinence in women: study of surgical practice in France

33. Saturated fatty acids alter the late secretory pathway by modulating membrane properties

34. Infant feeding patterns over the first year of life: influence of family characteristics

35. A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts

36. Rencontre entre histoire et médecine autour d’un verre d’azote-15

37. Menopause, hormone treatment and urinary incontinence at midlife

38. Malnutrition screening in clinical practice

39. Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion

40. Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes

41. The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells

42. The vitamin K–dependent anticoagulant factor, protein S, inhibits multiple VEGF-A–induced angiogenesis events in a Mer- and SHP2-dependent manner

43. Etude de l’effet du premier vecteur glucuronylé de la cyclopamine sur les cellules initiatrices de glioblastomes

44. Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers

45. Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study

46. Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: Implications for therapeutic use in prion diseases

47. What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?

Catalog

Books, media, physical & digital resources